Pleural fluid pseudouridine in malignant and benign pleural effusions

Annals of Clinical Biochemistry

Volumn 35, Issue 1, 1998, Pages 94-98

  Mak, T W L ^a   Ho, S S ^a   Ho, C S ^a   Jones, M G ^a   Lai, C K W ^a   Lam, C W K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Tumour marker

Indexed keywords

PSEUDOURIDINE; TUMOR MARKER;

AREA UNDER THE CURVE; ARTICLE; BREAST CANCER; CANCER; CANCER DIAGNOSIS; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIVER CANCER; LUNG CANCER; LYMPHOMA; MAJOR CLINICAL STUDY; NASOPHARYNX CANCER; PANCREAS CANCER; PLEURA EFFUSION; PLEURA FLUID; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STOMACH CANCER; TUBERCULOSIS;

EID: 0031973209     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1177/000456329803500112     Document Type: Article

References (28)

1. Mungall IPF, Cowen PN, Cooke NT, Roach TC, Cooke NJ. Multiple pleural biopsy with the Abram needle. Thorax 1980; 35: 600-2
2. Light RW, Erozan YS, Ball WC. Cells in pleural fluid. Their value in differential diagnosis. Arch Intern Med 1973; 132: 854-60
3. Sison BS, Weiss W. Needle biopsy of the parietal pleura in patients with pleural effusion. BMJ 1962; ii: 298-300
4. Seerbo J, Keltz H, Stone OJ. A prospective study of closed pleural biopsies, JAMA 1971; 218: 377-80
5. Prakash UBS, Reiman HM. Comparison of needle biopsy with cytologic analysis for the evaluation of pleural effusion: analysis of 414 cases. Mayo Clin Proc 1985; 60: 158-64
6. Dev D, Basran GS. Pleural effusion: a clinical review. Monaldi Arch Chest Dis 1994; 49: 25-35
7. Toubmis M, Chondros K, Ferderigos AS, Daganou M, Dema A, Dalamaga A, et al. Clinical evaluation of four tumor markers in malignant and benign pleural effusions. Anticancer Res 1992; 12: 1267-70
8. Kandylis K, Vassilomanokakis M, Baziotis N, Papadimitriou A, Tsoussis S, Ferderigou A, et al. Diagnostic significance of the tumour markers CEA, CA 15-3 and CA 125 in malignant effusions in breast cancer. Ann Oncol 1990; 1: 435-8
9. Gandhi AK, Nayar M, Bihari N, Chandra M. Diagnostic value of carcinoembryonic antigen assay of pleural and peritoneal effusions in malignancy. Indian J Med Res 1989; 90: 22-6
10. Whitaker D, Shilkin KB, Stuckey M, Nieuwhof WN. Pleural fluid CEA levels in the diagnosis of malignant mesothelioma. Pathology 1986; 18: 328-9
11. Imecik O, Ozer F. Diagnostic value of sialic acid in malignant pleural effusions. Chest 1992; 102: 1819-22
12. Motyl T, Traczyk Z, Ciesluk S, Daniewska-Michalska D, Kukulska W, Kaluzny Z, et al. Blood plasma pseudouridine in patients with malignant proliferative disease. Eur J Clin Chem Clin Biochem 1993; 31: 765-71
13. Salvatore F, Russo T, Colonna A, Cimino L, Mazzacca G, Cimino F. Pseudouridine determination in blood serum as tumor marker. Cancer Detect Prev 1983; 6: 531-6
14. Amuro Y, Nakaoka H, Shimomura S, Fujikura M, Yamamoto T, Tamura S, et al. Serum pseudouridine as a biochemical marker in patients with hepatocellular carcinoma. Clin Chim Acta 1988; 178: 151-8
15. Koshida K, Harmenberg J, Stendahl U, Wahren B, Borgstrom E, Helstrom L, et al. Urinary modified nucleosides as tumor markers in cancer of the urinary organs or female genital tract. Urol Res 1985; 13: 213-8
16. Sorensen SH, Brown DA, Cooper EH, Kelly KA, MacLennan IC. Urinary pseudouridine excretion in myelomatosis. Br J Cancer 1985; 52: 863-6
17. Rasmuson T, Bjork GR, Damber L, Holm SE, Jacobsson L, Jeppsson A, et al. Tumor markers in coloreclal carcinoma. An evaluation of carcinoembryonic antigen, tissue polypeptide antigen, placental alkaline phosphalase and pseudouridine. Acta Radiol Oncol 1984; 23: 27-32
18. Tamura S, Amuro Y, Nakano T, Fujii J, Moriwaki Y, Yamamoto R, et al. Urinary excretion of pseudouridine in patients with hepatocellular carcinoma. Cancer 1986; 57: 1571-5
19. Masuda M, Nishihira T, Itoh K, Mizugaki M, Ishida N, Mori S. An immunohistochemical analysis for cancer of the esophagus using monoclonal antibodies specific for modified nucleosides. Cancer 1993; 72: 3571-8
20. Li Y, Wang S, Zhong N. Simultaneous determination of pseudouridine and creatinine in urine of normal children and patients with leukaemia by high performance liquid chromatography. Biomed Chromatogr 1992; 6: 191-3
21. Bland JM, Altman DG. Multiple significance tests: the Bonferroni method. BMJ 1995; 310: 170
22. Zweig MH, Campbell G. Receiver-Operating Characteristic (ROC) Plots: A fundamental evaluation tool in clinical medicine. Clin Chem 1993; 39: 561-77
23. Buncher CR, Weiner D. Reference values. In: Kaplan LA, Pesce AJ, ed. Clinical Chemistry: Theory, Analysis, and Correlation. Missouri: CV Mosby, 1989: 267
24. Ehya H. Effusion Cytology. Clin Lab Med 1991; 11: 443-67
25. Nance KV, Shermer RW, Askin FB. Diagnostic efficacy of pleural biopsy as compared with that of pleural fluid examination. Mod Pathol 1991; 4: 320-4
26. Walshe AD, Douglas JG, Kerr KM, McKean ME, Godden DJ. An audit of the clinical investigation of pleural effusion. Thorax 1992; 47: 743-7
27. Suri JC, Goel A, Gupta DK, Bhatia A. Role of serial pleural biopsies in the diagnosis of pleural effusion. Indian J Chest Dis Allied Sci 1991; 33: 63-7
28. Woodcock A, Viskum K. Pleural and other investigations. In: Brewis R, Corrin B, Geddes DM, Gibson GJ, ed. Respiratory Medicine. London: WB Saunders, 1995: 383-91